| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| May 26, 2022 | Buy(P) | 20K | $3.04 | $61K | 5.2M |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001171843-22-003978) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Compass Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.